IASIOS FACILITY PROFILE
Maastricht UMC+
Maastricht · Netherlands · Europe
Accredited Centre
The Accredited Centre seal is a recognition of adherence to the CIRSE Standards of QA in IO, and represents a high standard of IO care provided by a facility.
About the facility
Maastricht University Medical Centre (Maastricht UMC+) is a public university medical centre in Maastricht, the Netherlands, combining specialist patient care, education and clinical research. Its Comprehensive Cancer Center brings together cancer diagnosis, treatment and supportive care across multiple specialties. The Interventional Radiology Department provides minimally invasive, image-guided treatments for tumours and metastases using CT, ultrasound and X-ray guidance. The hospital offers dedicated liver cancer treatment pathways, including thermal ablation and catheter-based therapies, with patient assessment and follow-up integrated into its wider cancer services.
Cancers and conditions treated
- Primary liver cancer, including hepatocellular carcinoma
- Liver tumours and metastases suitable for image-guided treatment
- Other selected tumours and metastases suitable for local ablation or embolisation
- Tumour-related biliary obstruction
Interventional oncology procedures
- Radiofrequency ablation (RFA)
- Microwave ablation (MWA)
- Cryoablation
- Transarterial chemoembolisation (TACE)
- Selective internal radiation therapy (SIRT/radioembolisation)
- Transarterial tumour embolisation
- Percutaneous biliary drainage and stenting
Our IASIOS experience
“We are extremely proud to have received the IASIOS accreditation. Joining IASIOS helped us to enhance our oncology services and ensure the highest standards of patient care. The accreditation process was thorough and collaborative, providing us with valuable insights and opportunities for improvement. Since obtaining the accreditation, we’ve seen increased trust from patients and recognition within the medical community. We expect continued benefits in providing state of the art therapies and fostering innovation in our practices.”